Cargando…
Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer
Conventional chemotherapy of ovarian cancer often fails because of initiation of drug resistance and/or side effects and trace of untouched remaining cancerous cells. This highlights an urgent need for advanced targeted therapies for effective remediation of the disease using a cytotoxic agent with...
Autores principales: | Matthaiou, Efthymia-Iliana, Barar, Jaleh, Sandaltzopoulos, Raphael, Li, Chunsheng, Coukos, George, Omidi, Yadollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998853/ https://www.ncbi.nlm.nih.gov/pubmed/24790428 http://dx.doi.org/10.2147/IJN.S51880 |
Ejemplares similares
-
TEM1-targeting PEGylated PLGA shikonin nanoformulation for immunomodulation and eradication of ovarian cancer
por: Matthaiou, Efthymia-Iliana, et al.
Publicado: (2022) -
Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells
por: Aghanejad, Ayuob, et al.
Publicado: (2018) -
Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells
por: Torabi, Mitra, et al.
Publicado: (2023) -
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
por: Omidi, Yadollah, et al.
Publicado: (2014) -
Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
por: Barar, Jaleh, et al.
Publicado: (2014)